Alapatt Thomas
Internal Medicine · Union, NJNPI 1386601060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,188 and has fallen 98.5% since, to $34 in 2025.
Across 106 payments — averaging $24.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$428
- Amarin Pharma, Inc.$367
- GSK$331
- Johnson & Johnson$284
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$176
- Boehringer Ingelheim$151
- plus $817 from 18 others
What the payments were for
- Food & beverage$2,53699%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $428 |
| Amarin Pharma, Inc. | 8 | $367 |
| GSK | 8 | $331 |
| Johnson & Johnson | 5 | $284 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $176 |
| Boehringer Ingelheim | 5 | $151 |
| Novartis | 12 | $148 |
| Novo Nordisk | 2 | $141 |
| Merck | 12 | $125 |
| Amgen(2 entities) | 8 | $110 |
| Lilly USA, LLC | 4 | $57 |
| Boston Scientific | 1 | $34 |
| Zyla Life Sciences, Inc. | 2 | $28 |
| Astellas Pharma US Inc | 2 | $26 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Mylan Specialty L.p. | 1 | $19 |
| Mannkind Corporation | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Medicure Pharma Inc. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Pfizer | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,553 in reported general payments places this provider in the 80th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omega-3 Acid Ethyl Esters | 12 | $264 |
| Tamsulosin Hcl | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Union
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.